138 related articles for article (PubMed ID: 38219506)
1. Long-Term Survival Following Primary Graft Dysfunction Development in Lung Transplantation.
Gouchoe DA; Whitson BA; Rosenheck J; Henn MC; Mokadam NA; Ramsammy V; Kirkby S; Nunley D; Ganapathi AM
J Surg Res; 2024 Apr; 296():47-55. PubMed ID: 38219506
[TBL] [Abstract][Full Text] [Related]
2. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
Eberlein M; Reed RM; Bolukbas S; Diamond JM; Wille KM; Orens JB; Brower RG; Christie JD;
J Heart Lung Transplant; 2015 Feb; 34(2):233-40. PubMed ID: 25447586
[TBL] [Abstract][Full Text] [Related]
3. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
[TBL] [Abstract][Full Text] [Related]
4. Impact of anastomosis time during lung transplantation on primary graft dysfunction.
Vandervelde CM; Vos R; Vanluyten C; Fieuws S; Verleden SE; Van Slambrouck J; De Leyn P; Coosemans W; Nafteux P; Decaluwé H; Van Veer H; Depypere L; Dauwe DF; De Troy E; Ingels CM; Neyrinck AP; Jochmans I; Vanaudenaerde BM; Godinas L; Verleden GM; Van Raemdonck DE; Ceulemans LJ
Am J Transplant; 2022 May; 22(5):1418-1429. PubMed ID: 35029023
[TBL] [Abstract][Full Text] [Related]
5. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
Warnecke G; Van Raemdonck D; Smith MA; Massard G; Kukreja J; Rea F; Loor G; De Robertis F; Nagendran J; Dhital KK; Moradiellos Díez FJ; Knosalla C; Bermudez CA; Tsui S; McCurry K; Wang IW; Deuse T; Lesèche G; Thomas P; Tudorache I; Kühn C; Avsar M; Wiegmann B; Sommer W; Neyrinck A; Schiavon M; Calabrese F; Santelmo N; Olland A; Falcoz PE; Simon AR; Varela A; Madsen JC; Hertz M; Haverich A; Ardehali A
Lancet Respir Med; 2018 May; 6(5):357-367. PubMed ID: 29650408
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
[TBL] [Abstract][Full Text] [Related]
7. Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States - a cohort study.
Jawitz OK; Raman V; Bryner BS; Klapper J; Hartwig MG
Transpl Int; 2021 Jan; 34(1):194-203. PubMed ID: 33145853
[TBL] [Abstract][Full Text] [Related]
8. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
9. Extended recipients but not extended donors are associated with poor outcomes following lung transplantation.
Moreno P; Alvarez A; Santos F; Vaquero JM; Baamonde C; Redel J; Cerezo F; Algar FJ; Salvatierra A
Eur J Cardiothorac Surg; 2014 Jun; 45(6):1040-7. PubMed ID: 24163362
[TBL] [Abstract][Full Text] [Related]
10. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.
Felten ML; Sinaceur M; Treilhaud M; Roze H; Mornex JF; Pottecher J; Journois D; Fischler M
Eur J Cardiothorac Surg; 2012 Mar; 41(3):686-90. PubMed ID: 22345188
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation.
Squiers JJ; DiMaio JM; Van Zyl J; Lima B; Gonzalez-Stawisnksi G; Rafael AE; Meyer DM; Hall SA
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1178-1183. PubMed ID: 34100537
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
[TBL] [Abstract][Full Text] [Related]
14. Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation.
Li D; Weinkauf J; Kapasi A; Hirji A; Varughese R; Lien D; Nagendran J; Halloran K
Respir Med; 2021 Nov; 188():106617. PubMed ID: 34571454
[TBL] [Abstract][Full Text] [Related]
15. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
16. Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.
Tague LK; Bedair B; Witt C; Byers DE; Vazquez-Guillamet R; Kulkarni H; Alexander-Brett J; Nava R; Puri V; Kreisel D; Trulock EP; Gelman A; Hachem RR
J Heart Lung Transplant; 2021 Oct; 40(10):1212-1222. PubMed ID: 34353713
[TBL] [Abstract][Full Text] [Related]
17. The role of mechanical ventilation in primary graft dysfunction in the postoperative lung transplant recipient: A single center study and literature review.
Niroomand A; Qvarnström S; Stenlo M; Malmsjö M; Ingemansson R; Hyllén S; Lindstedt S
Acta Anaesthesiol Scand; 2022 Apr; 66(4):483-496. PubMed ID: 35014027
[TBL] [Abstract][Full Text] [Related]
18. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
[TBL] [Abstract][Full Text] [Related]
19. Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation.
Frick AE; Verleden SE; Ordies S; Sacreas A; Vos R; Verleden GM; Vanaudenaerde BM; Claes S; Schols D; Van Raemdonck DE; Neyrinck AP
Eur J Cardiothorac Surg; 2020 Aug; 58(2):379-388. PubMed ID: 32267918
[TBL] [Abstract][Full Text] [Related]
20. Donor Club Cell Secretory Protein G38A Polymorphism Is Associated With a Decreased Risk of Primary Graft Dysfunction in the French Cohort in Lung Transplantation.
Hin A; Kannengiesser C; Roussel A; Renaud-Picard B; Roux A; Reynaud-Gaubert M; Claustre J; Tissot A; Guillemain R; Mornex JF; Mussot S; Dromer C; Dahan M; Brugière O; Mercier O; Borie R; Pretolani M; Castier Y; Mordant P;
Transplantation; 2018 Aug; 102(8):1382-1390. PubMed ID: 29470356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
